Concepedia

Michael R. Michaelides

MR

22

Publications

1K

Citations

19

H-Index

1987

Active since

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

Michael R. Michaelides is an author at Abbott Fund specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1987–2012

22

Publications

22

Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors

Yujia Dai, Yan Guo, Robin R. Frey et al. · Journal of Medicinal Chemistry · 2005 · 152 citations · Full text

, , +17

A highly stereoselective synthesis of (+)-olivin, the aglycon of olivomycin A

William Roush, Michael R. Michaelides, Dar Fu Tai et al. · Journal of the American Chemical Society · 1989 · 92 citations

, , +12

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Deepa Shankar, Junling Li, Paul Tapang et al. · Blood · 2007 · 84 citations · Full text

Recent Advances in Matrix Metalloproteinase Inhibitors Research

Michael R. Michaelides, Michael L. Curtin · Current Pharmaceutical Design · 1999 · 79 citations

, , +14

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors

Jun Guo, Patrick A. Marcotte, Jennifer McCall et al. · Molecular Cancer Therapeutics · 2006 · 65 citations · Full text

Rows per page

1–5 of 22